Ignite Creation Date:
2025-12-25 @ 2:48 AM
Ignite Modification Date:
2026-02-28 @ 9:39 PM
Study NCT ID:
NCT02776033
Status:
COMPLETED
Last Update Posted:
2020-07-08
First Post:
2016-05-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Repeat Doses of GSK2982772 in Subjects With Psoriasis
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-08-30
Start Date Type:
ACTUAL
Primary Completion Date:
2018-01-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-01-04
Completion Date Type:
ACTUAL
First Submit Date:
2016-05-16
First Submit QC Date:
None
Study First Post Date:
2016-05-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-06-20
Results First Submit QC Date:
None
Results First Post Date:
2019-08-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-06-26
Last Update Post Date:
2020-07-08
Last Update Post Date Type:
ACTUAL